… at the Food and Drugs Authority (FDA), Pharm. Patrick Owusu- … with the African Media and Malaria Research Network, AMMREN, and … Ghana Health Service, Dr. (Med) Naziru Tanko Mohammed, revealed that … their key challenges. Dr. (Med) Mohammed therefore urged the …

… protocol analysis. The trial studied 1,688 adults … mutant malaria parasites associated with partial drug resistance. The treatment was … trials and other antimalarial drugs. The principal stratum … of study medication) and took non-study treatment with …

… comfortable breezes are enveloping the Pharmalot campus, where the official mascots … explains. But critics — including some drug companies — argue the moves would … a potential new treatment cured more than 99% of malaria cases in …

… the new malaria treatment KLU156 (ganaplacide/lumefantrine, or GanLum). This drug was … represent the biggest advance in malaria treatment for decades, with high efficacy … .  If approved, the drug could be used to treat international travelers returning …

… new treatments to help combat malaria’s growing resistance to existing drugs, … said a trial of its next-generation treatment in 12 … African countries had performed well, though the drug … mixture of four anti-malarial medications led to 93% of …

… Swiss pharmaceutical giant Novartis. In a late-stage trial, it … resistance to the current drugs. Once pathogens like … existing drugs, infectious diseases become harder to treat and … biggest advance in malaria treatment for decades”. “Drug resistance is a …

… treatment of malaria, with a new phase 3 trial showing efficacy for a drug … the treatment was highly effective against mutant malaria parasites associated with partial drug … represent the biggest advance in malaria treatment for decades, with high efficacy …

… pharmaceutical companies are planning to export medications to Russia. These “miracle drugs” supposedly treat … the drug is effective against hepatitis, malaria, tuberculosis … medications actually work. No clinical trial … call the “best remedy” for dozens of …

… the first new class of malaria drug approved in more than 25 … need for non-artemisinin-based drugs to treat malaria,” says Philip Rosenthal, a … , a standard artemisinin-based treatment for malaria. The trial included 1,688 adults …

… States Food and Drug Administration (FDA) for the treatment of acute canine … treatment and prevention of vector-borne disease. 60 Degrees Pharmaceuticals, Inc. achieved FDA … (tafenoquine), for malaria prevention, in 2018. 60 Degrees Pharmaceuticals, Inc. also …